Milind M Javle

36PUBLICATIONS
351CO-AUTHORS
ChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Water treatment processesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 10, 2026
Ex vivo tumor derived organoid pharmacotyping identifies personalized therapeutic options for biliary tract cancer patients.

|Jul 23, 2026
Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Jun 03, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.

|Apr 02, 2026
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.

Joseph Abi Jaoude, Alexandria Lau, Yinyin Yuan

|Mar 30, 2026
Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation Therapy.

Srinivas Cheenu Kappadath, Ahmed Kaseb, Milind Javle

Pageof 6

Frequent Collaborators

8 joint publications

Funda Meric-Bernstam

7 joint publications

Shubham Pant

5 joint publications

Jordi Rodon Ahnert

5 joint publications

Lawrence N Kwong